136 related articles for article (PubMed ID: 37596162)
41. Raman spectroscopy combined with machine learning algorithms for rapid detection Primary Sjögren's syndrome associated with interstitial lung disease.
Wu X; Chen C; Chen X; Luo C; Lv X; Shi Y; Yang J; Meng X; Chen C; Su J; Wu L
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103057. PubMed ID: 35944848
[TBL] [Abstract][Full Text] [Related]
42. Pulmonary manifestations of Sjögren's syndrome.
Shi JH; Liu HR; Xu WB; Feng RE; Zhang ZH; Tian XL; Zhu YJ
Respiration; 2009; 78(4):377-86. PubMed ID: 19390161
[TBL] [Abstract][Full Text] [Related]
43. Characteristics and mortality in primary Sjögren syndrome-related interstitial lung disease.
Gao H; Sun Y; Zhang XY; Xie L; Zhang XW; Zhong YC; Zhang J; Hou YK; Li ZG
Medicine (Baltimore); 2021 Sep; 100(35):e26777. PubMed ID: 34477117
[TBL] [Abstract][Full Text] [Related]
44. [The effect of cyclophosphamide on cytokines in patients with primary Sjögren's syndrome-associated interstitial lung disease].
Mo HY; Wang LF; Xu J; Shi YH; Yang M; Zhou RH
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jul; 34(7):495-9. PubMed ID: 22041773
[TBL] [Abstract][Full Text] [Related]
45. [Screening for serum specific biomarkers in patients with primary Sjögren's syndrome and interstitial lung disease using proteomic fingerprint techniques].
Li YH; Sun XL; He J; Jia RL; Yang DY; Zhang XW; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):240-3. PubMed ID: 22516996
[TBL] [Abstract][Full Text] [Related]
46. Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology.
Sambataro G; Ferro F; Orlandi M; Sambataro D; Torrisi SE; Quartuccio L; Vancheri C; Baldini C; Matucci Cerinic M
Autoimmun Rev; 2020 Feb; 19(2):102447. PubMed ID: 31843713
[TBL] [Abstract][Full Text] [Related]
47. The characteristics of chest HRCT and pulmonary function tests in lung-onset primary sjogren's syndrome.
Dong X; Gao Y; Li M; Wang D; Li J; Zhang Y
Immun Inflamm Dis; 2023 Aug; 11(8):e957. PubMed ID: 37647425
[TBL] [Abstract][Full Text] [Related]
48. Quantitative analysis of Sjogren's syndrome related interstitial lung disease with different methods.
Ufuk F; Demirci M; Altinisik G; Karasu U
Eur J Radiol; 2020 Jul; 128():109030. PubMed ID: 32388319
[TBL] [Abstract][Full Text] [Related]
49. Effect of cyclophosphamide on cytokines in patients with primary Sjögren's syndrome-associated interstitial lung disease in South China.
Zhang L; Mo H; Zhu M; Wang L
Rheumatol Int; 2013 Jun; 33(6):1403-7. PubMed ID: 23143555
[TBL] [Abstract][Full Text] [Related]
50. Hsa_circ_0008301 as a potential biomarker of disease activity for primary Sjogren's syndrome: Increased expression in peripheral blood of patients with primary Sjogren's syndrome.
Ji J; Zhang X; Ling Y; Tian J; Wang Y; Luo Y; Zhu R; Zhou Y; Zhu T; Wang L; Zhu H
Int Immunopharmacol; 2022 Nov; 112():109231. PubMed ID: 36113315
[TBL] [Abstract][Full Text] [Related]
51. Clinical outcomes and risk factors of progressive pulmonary fibrosis in primary Sjögren's syndrome-associated interstitial lung disease.
Chen YH; Lee TJ; Hsieh HJ; Hsieh SC; Wang HC; Chang YC; Yu CJ; Chien JY
BMC Pulm Med; 2023 Jul; 23(1):268. PubMed ID: 37468847
[TBL] [Abstract][Full Text] [Related]
52. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
Front Immunol; 2021; 12():673658. PubMed ID: 34012457
[TBL] [Abstract][Full Text] [Related]
53. Lung Involvement in Primary Sjögren's Syndrome-An Under-Diagnosed Entity.
Sogkas G; Hirsch S; Olsson KM; Hinrichs JB; Thiele T; Seeliger T; Skripuletz T; Schmidt RE; Witte T; Jablonka A; Ernst D
Front Med (Lausanne); 2020; 7():332. PubMed ID: 32766261
[TBL] [Abstract][Full Text] [Related]
54. Factors associated with secondary immune thrombocytopenia in patients with primary Sjögren's syndrome: a retrospective study of 639 cases.
Luo J; Song WJ; Chen JQ; Yang GY; Yang JY; Yu XB; Huang ZW; Xu Y; Wang JM; Tao QW
Clin Exp Rheumatol; 2022 Dec; 40(12):2245-2252. PubMed ID: 35383565
[TBL] [Abstract][Full Text] [Related]
55. Interstitial lung disease and associated factors in patients with Sjögren's syndrome.
Sargın G; Baygin H; Cildag S; Senturk T
Ir J Med Sci; 2024 Jun; 193(3):1385-1389. PubMed ID: 38363440
[TBL] [Abstract][Full Text] [Related]
56. Distribution and clinical significance of anti-carbamylation protein antibodies in rheumatological diseases among the Chinese Han population.
Dong R; Sun Y; Xu W; Xiang W; Li M; Yang Q; Zhu L; Ma Z
Front Immunol; 2023; 14():1197458. PubMed ID: 37539050
[TBL] [Abstract][Full Text] [Related]
57. Anti-Ro52 Antibody as a Protective Factor for Pulmonary Fibrosis in Primary Sjögren's Syndrome.
Li D; Li H; Li W; Zhu T
Iran J Immunol; 2022 Jun; 19(2):161-171. PubMed ID: 35767889
[TBL] [Abstract][Full Text] [Related]
58. Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome.
Zhao L; Yao L; Yuan L; Xia L; Shen H; Lu J
Cytokine; 2013 Oct; 64(1):22-4. PubMed ID: 23910012
[TBL] [Abstract][Full Text] [Related]
59. Pulmonary involvement in Sjögren's syndrome.
Mestre-Torres J; Solans-Laque R
Med Clin (Barc); 2022 Feb; 158(4):181-185. PubMed ID: 34392987
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren's Syndrome Complicated with Interstitial Lung Disease.
Wei F; Zhang X; Yang S; Geng J; Xie B; Ren Y; Dai H
J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
